Delivery Order SPE2DB24D6039-SPE2DB24FLDWY

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,547.45 firm fixed-price delivery order is for the supply of 4,567,240,539 units of Atomoxetine HCL 40 mg capsules. The contract has an ultimate completion date of February 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Atomoxetine HCL 10 mg capsules. The contract has a potential value of $1,721.75 and a completion date of February 2, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA Troop Support...
This federal contract award, valued at $1,699.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor, for the delivery of Atomoxetine HCL 40 mg capsules. The contract has a completion date of February 13, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
The Defense Logistics Agency awarded a $321,830 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561866297 Atomoxetine HCl 80 mg capsules. Under this order, Amerisourcebergen will deliver 30 capsules to a location in Conshohocken, Pennsylvania by August 21, 2023 to support the DLA's medical supply needs. As a top 10 defense contractor, Amerisourcebergen regularly fulfills delivery orders for pharmaceuticals and other medical supplies through existing Prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,332.93 firm fixed-price delivery order is for the supply of 4566771107 - Atomoxetine HCL 40 mg capsules in quantities of 30s. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,255 units of Atomoxetine HCL 40 mg capsules. The contract has a Firm Fixed Price (FFP) pricing structure and a total ceiling value of $1,307.21. It was awarded on July 25, 2024 with a period of performance through July 26, 2024. This contract represents a delivery order under AmerisourceBergen's $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,038.83 firm fixed price delivery order is for the supply of the prescription medication atomoxetine hydrochloride 25mg capsules. The contract has an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,391.63, is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Atomoxetine HCL 25 mg capsules, a generic pharmaceutical product. The contract has a ceiling value of $1,600.04 and runs through February 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4,563,846,679 units of Atomoxetine HCl 40 mg capsules in 30-count packages, with a potential value of $2,107.30 and a performance period ending on March 5, 2024. The contract does not have a set-aside...
  • SPE2DB24D6039
    Indefinite Delivery Contract
  • SPE2DB24D6039-SPE2DB24FLDWY
    Delivery Order

This is a delivery order (SPE2DB24D6039|SPE2DB24FLDWY) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,291 units of 80 mg Atomoxetine HCL capsules. The $1,006.68 firm fixed-price contract has a completion date of July 31, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of critical medical commodities, including prescription drugs, vaccines, and medical supplies, to support military healthcare programs and other federal beneficiaries. This contract award is not associated with a set-aside program.

Generated 10/29/24, 9:04 AM